Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life.

Quality of life measures are increasingly used as important efficacy endpoints in studies of drugs for asthma. The purpose of this study was to assess both the sensitivity to change and the construct validity of four different quality of life instruments in patients with asthma. In a double-blind, parallel group study, 120 moderate asthma patients, aged between 18-70 yrs, received either inhaled salmeterol 50 micrograms b.i.d. or inhaled salbutamol 400 micrograms b.i.d. In addition to respiratory outcomes, quality of life was measured at a 6 weeks follow-up using: 1) Asthma Quality of Life Questionnaire (AQLQ); 2) Living With Asthma Questionnaire (LWAQ); 3) Sickness Impact Profile (SIP); 4) Rating Scale (RS); and Standard Gamble (SG) utilities. Salmeterol led to significant improvements over salbutamol on virtually all clinical outcomes. Although all the quality of life instruments showed the same trend in favour of salmeterol, only the AQLQ and RS utilities showed significantly greater improvement on salmeterol than on salbutamol. Except for the AQLQ, the correlation between change in lung function and change in quality of life was generally low. Whereas, the AQLQ correlated well with the patient's overall assessment of efficacy (r = 0.64), the LWAQ, SIP and utilities failed to show such a correlation. The AQLQ showed the best correlation with symptom scores. The cross-sectional correlation between the AQLQ and the LWAQ was 0.73, whereas the longitudinal correlation was only 0.29. The SG generally showed poor correlation with other measures, including the RS. In conclusion, patients given salmeterol showed a greater improvement in quality of life compared to patients given salbutamol. Of the disease-specific questionnaires the Asthma Quality of Life Questionnaire was found to be more responsive to change than the Living With Asthma Questionnaire and showed greater validity. Of the generic instruments, the rating scale utilities were most responsive. The Standard Gamble showed poor correlation with other measures.

[1]  S. van der Linden,et al.  Feasibility of utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia. , 1994, The Journal of rheumatology.

[2]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.

[3]  P. Jones,et al.  Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. , 1994, The European respiratory journal.

[4]  C. Bombardier,et al.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. , 1993, Journal of clinical epidemiology.

[5]  A. Woolcock,et al.  An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma. , 1993, Journal of clinical epidemiology.

[6]  B. H. Rowe,et al.  Performance of an asthma quality of life questionnaire in an outpatient setting. , 1993, The American review of respiratory disease.

[7]  M. Hyland.  The validity of health assessments: resolving some recent differences. , 1993, Journal of clinical epidemiology.

[8]  Michael D. Hughes,et al.  Issues in the Design of Long-Term Clinical Trials in Asthma , 1993 .

[9]  Quality of Life Studies from the Perspective of an FDA Reviewing Statistician* , 1993 .

[10]  E. Juniper,et al.  Quality of life of subjects with occupational asthma. , 1993, The Journal of allergy and clinical immunology.

[11]  E. van Doorslaer,et al.  Health related utility measurement in rheumatology: an introduction. , 1993, Patient education and counseling.

[12]  G. Guyatt,et al.  Measuring quality of life in asthma. , 1993, The American review of respiratory disease.

[13]  J. Palmer,et al.  Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group. , 1993, Thorax.

[14]  G H Guyatt,et al.  Measuring health status: what are the necessary measurement properties? , 1992, Journal of clinical epidemiology.

[15]  J. Kemp,et al.  A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. , 1992, The New England journal of medicine.

[16]  C. van Weel,et al.  Two-year bronchodilator treatment in patients with mild airflow obstruction. Contradictory effects on lung function and quality of life. , 1992, Chest.

[17]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[18]  A. Woolcock,et al.  A scale for the measurement of quality of life in adults with asthma. , 1992, Journal of clinical epidemiology.

[19]  G. Guyatt,et al.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. , 1992, Thorax.

[20]  H. Kotses,et al.  A life activities questionnaire for adult asthma. , 1992, The Journal of asthma : official journal of the Association for the Care of Asthma.

[21]  Ingela Wiklund,et al.  Cross-cultural adaptation of health measures , 1991 .

[22]  M. Hyland.  The Living with Asthma Questionnaire. , 1991, Respiratory medicine.

[23]  George W. Torrance,et al.  Methodologic challenges in the development of utility measures of health-related quality of life in rheumatoid arthritis. , 1991, Controlled clinical trials.

[24]  R A Deyo,et al.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. , 1991, Controlled clinical trials.

[25]  M. Hyland,et al.  A scale for assessing quality of life in adult asthma sufferers. , 1991, Journal of psychosomatic research.

[26]  N. Douglas,et al.  Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. , 1990, BMJ.

[27]  K. A. Johnston,et al.  Quality of life bibliography and indexes. , 1990, Medical care.

[28]  F. Dekker,et al.  Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice. , 1990, Chest.

[29]  J. Hedner,et al.  Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. , 1990, The American review of respiratory disease.

[30]  M. Bury,et al.  Impairment, disability and handicap in chronic respiratory illness. , 1989, Social science & medicine.

[31]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[32]  G. Torrance.  Measurement of health state utilities for economic appraisal. , 1986, Journal of health economics.

[33]  G. Guyatt,et al.  Should study subjects see their previous responses? , 1985, Journal of chronic diseases.

[34]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.

[35]  I. Grant,et al.  Chronic obstructive pulmonary disease; socioemotional adjustment and life quality. , 1980, Chest.